Alyeska Investment Group, L.P. Health Catalyst, Inc. Transaction History
Alyeska Investment Group, L.P.
- $25 Billion
- Q4 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 2,019,380 shares of HCAT stock, worth $10.9 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,019,380
Previous 1,158,230
74.35%
Holding current value
$10.9 Million
Previous $9.43 Million
51.45%
% of portfolio
0.06%
Previous 0.05%
Shares
13 transactions
Others Institutions Holding HCAT
# of Institutions
177Shares Held
50.5MCall Options Held
2.97MPut Options Held
16.1K-
Black Rock Inc. New York, NY5.43MShares$29.4 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN5.24MShares$28.4 Million3.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.39MShares$23.8 Million0.0% of portfolio
-
Impax Asset Management Group PLC2.75MShares$14.9 Million0.1% of portfolio
-
Daventry Group, LP New York, NY2.51MShares$13.6 Million6.78% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $297M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...